Reducing High-Risk Geriatric Polypharmacy via EHR Nudges
Description: Project Narrative Polypharmacy is common among older adults in the United States and is associated with harms such as adverse drug reactions, drug interactions, falls, and higher costs of care. This project aims to develop and conduct a randomized trial of electronic health record (EHR)-based behavioral economic nudges to help clinicians reduce the rate of high-risk polypharmacy among their older adult patients. If these nudges prove effective, they can be deployed in EHRs throughout the country to lower the risk of medication-induced harm, thereby improving the health and safety of older adults.
Funder: National Institute on Aging
Funding type: research
Funder scheme: R21
Start date: 2017-09-30
End date: 2019-08-31
Investigator: MARK WILLIAM FRIEDBERG (lead)
Institution: RAND Corporation
Subfield: Geriatrics and Gerontology
Field: Medicine
Domain: Health Sciences
Funded outputs count: 9
Funder award ID: R21AG057396
OpenAlex ID: G5834341923
